Advertisement
AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


AJPH First Look, published online ahead of print Jun 12, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2007.120741v1
98/8/1430    most recent
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shaw, S. Y.
Right arrow Articles by Wylie, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shaw, S. Y.
Right arrow Articles by Wylie, J. L.
Related Collections
Right arrow Epidemiology
Right arrow HIV/AIDS
Right arrow Drugs
August 2008, Vol 98, No. 8 | American Journal of Public Health 1430-1437
© 2008 American Public Health Association
DOI: 10.2105/AJPH.2007.120741


INNOVATIONS IN DESIGN AND ANALYSIS

Identifying Heterogeneity Among Injection Drug Users: A Cluster Analysis Approach

Souradet Y. Shaw, BA, Lena Shah, MSc, Ann M. Jolly, PhD and John L. Wylie, PhD

At the time of this study, Souradet Y. Shaw and Lena Shah were with the Department of Community Health Sciences, University of Manitoba, Winnipeg. Ann M. Jolly is with the Centre for Infectious Disease Prevention and Control, Population and Public Health Branch, Health Canada, Ottawa, Ontario, and the Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa. John L. Wylie is with the Departments of Medical Microbiology and Community Health Sciences, University of Manitoba, Winnipeg, and Cadham Provincial Laboratory, Manitoba Health, Winnipeg.

Correspondence: Requests for reprints should be sent to John L. Wylie, PhD, Cadham Provincial Laboratory, 750 William Ave, Winnipeg, Manitoba R3C 3Y1, Canada (e-mail: john. wylie{at}gov.mb.ca).

ABSTRACT

Objectives. We used cluster analysis to subdivide a population of injection drug users and identify previously unknown behavioral heterogeneity within that population.

Methods. We applied cluster analysis techniques to data collected in a cross-sectional survey of injection drug users in Winnipeg, Manitoba. The clustering variables we used were based on receptive syringe sharing, ethnicity, and types of drugs injected.

Results. Seven clusters were identified for both male and female injection drug users. Some relationships previously revealed in our study setting, such as the known relationship between Talwin (pentazocine) and Ritalin (methylphenidate) use, injection in hotels, and hepatitis C virus prevalence, were confirmed through our cluster analysis approach. Also, relationships between drug use and infection risk not previously observed in our study setting were identified, an example being a cluster of female crystal methamphetamine users who exhibited high-risk behaviors but an absence or low prevalence of blood-borne pathogens.

Conclusions. Cluster analysis was useful in both confirming relationships previously identified and identifying new ones relevant to public health research and interventions.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Public Health Association